Figures & data
Figure 1. Flow-chart of patient population, by study groups
Table 1. Study population according to medical condition
Figure 2. Anti-HBs titer after booster vaccine dose, by study group
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 2
Letter
The role of hepatitis B vaccine challenge dose in patients with underlying health conditions
L. Sticchia Department of Health Sciences (Dissal), University of Genoa, Genoa, Italy;b Hygiene Unit, IRCCS Policlinico San Martino Hospital, Genoa, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-7819-7400
https://orcid.org/0000-0002-7819-7400, I. G. Iavaronea Department of Health Sciences (Dissal), University of Genoa, Genoa, Italyhttps://orcid.org/0000-0002-0096-7938
https://orcid.org/0000-0002-0096-7938, P. Durandoa Department of Health Sciences (Dissal), University of Genoa, Genoa, Italy;c Occupational Medicine Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italyhttps://orcid.org/0000-0001-5047-5176
https://orcid.org/0000-0001-5047-5176, , , & G. Icardia Department of Health Sciences (Dissal), University of Genoa, Genoa, Italy;b Hygiene Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italyhttps://orcid.org/0000-0002-8463-8487
https://orcid.org/0000-0002-8463-8487 show all